Cathie Wood Buys $3.6M of HOOD, Sells $2.9M of 2 High-Growth Stocks – September 5
Cathie Wood-led ARK Invest made several notable trades on Friday, September 4, with Robinhood Markets ($HOOD), an online brokerage and financial-se...
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
Moderna Stock (MRNA) Drops as Rothschild Downgrades to ‘Sell’ on Valuation Concerns
Moderna ($MRNA) stock was down about 3% in Thursday’s pre-market trading after Rothschild Redburn analyst Simon Baker downgraded his rating on the ...
RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth
RedHill Biopharma ($RDHL) divested its Talicia business to Apotex Health Corp. in an $18 million upfront plus potential milestones deal as part of ...
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck's Trial Results Encouraging
August has been a great month for the shares of Merck & Co., Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), to say the least.
Healthcare's Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial
The health-care sector was on track for its strongest week since June 26, with the Health Care index rising more than 4% in the five trading days leading up to August 21, compared to a 7.9% increase in...
3 ETFs to Buy with 10%+ Total Returns, According to the AI Analyst
TipRanks’ ETF AI Analyst has an Outperform rating on the Invesco NASDAQ 100 ETF ($QQQM), Vanguard High Dividend Yield Index ETF ($VYM), and iShares...
BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why
BioNTech ($BNTX) shares declined as much as 10% on Friday after the company said it has ended a key Phase 2 trial for its mRNA colorectal cancer va...
Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial
On August 19, 2026, Moderna, Inc. (NASDAQ:MRNA) and Merck & Co., Inc.
Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks?
On August 19, 2026, Moderna, Inc. (NASDAQ:MRNA) and Merck & Co., Inc.
Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck
Biotech firm Moderna ($MRNA) saw its stock rise 12.5% today, building on a multi-day rally after releasing positive Phase 3 trial data for its pers...
Hedge Fund Resource Center